Kévin Beccaria

12PUBLICATIONS
155CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Haematological tumoursPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 10, 2026
DNMT3B plays antagonistic roles with SMARCB1 and is a targetable vulnerability in rhabdoid tumors.

|Nov 11, 2025
Clinical and molecular landscape of paediatric cerebral and spinal cavernous malformations.

Sandro Benichi, Estelle Balducci, Joseph Benzakoun

|Aug 02, 2024
Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumors.

Grégory Thomson, Mathilde Filser, Léa Guerrini-Rousseau

|Jul 04, 2024
Medulloblastomas with ELP1 pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age window.

Léa Guerrini-Rousseau, Julien Masliah-Planchon, Mathilde Filser

|Mar 11, 2024
Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study.

Alice Morin, Rodrigue Allodji, Dulanjalee Kariyawasam

|Jan 18, 2024
"Hemispheric pilocytic astrocytoma" revisited: A comprehensive clinicopathological and molecular series emphasizing their overlap with other glioneuronal tumors.

Cassandra Mariet, Jacques Grill, Yassine Ajlil

Pageof 2